CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Angiogenex Inc Company Snapshot
Angiogenex Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Angiogenex Inc with three other companies in this sector in the United States: Abeona Therapeutics Inc (2007 sales of $57,000.00 of which 100% was Advanced polymer), International Stem Cell Corporation ($38,764.00 of which 100% was Therapeutic Product and Development), and Metabolic Research, Inc. ($54,026.00 of which 100% was Online Information Services).

Sales Analysis.
   
   
 
  Stock Performance Chart for Angiogenex Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (10/28/2019): .10
(Figures in U.S. Dollars)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
 
Angiogenex Inc Key Data:
  Ticker: AGGX Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2007 Sales 50,000
(Year Ending Jan 2008).
Employees:
  Currency: U.S. Dollars Market Cap: 3,160,213
  Fiscal Yr Ends: December Shares Outstanding: 30,386,667
  Share Type: Closely Held Shares: 16,037,677
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.